UNITY Biotechnology, Inc. UNBX
0.06
0.00
0.00%
as of 14 Oct
- Market cap
- $3.4M
- P/E
- 0.0×
Follow UNBX
Growth Flags
show if company had growth for consecutive years
| Older periods | Jun '24 | Sep '24 | Dec '24 | Mar '25 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
3.85 | 3.31 | 2.51 | 1.87 | |
Current Ratio |
4.07 | 3.45 | 2.62 | 1.95 | |
Net Debt/EBITDA |
4.88 | 4.43 | 3.23 | 2.49 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.80 | 0.70 | 0.87 | |
Capex/Depreciation |
0.00 | 0.13 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.27) | (0.31) | (0.35) | (0.38) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.27) | (0.31) | (0.35) | (0.38) | |
Cash per Share |
2.02 | 1.72 | 1.38 | 1.00 | |
Shareholders Equity per Share |
1.17 | 0.84 | 0.39 | (0.01) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.17 | 0.84 | 0.39 | (0.01) | |
Free Cash Flow |
(4.58) | (5.19) | (5.90) | (6.36) | |
Working Capital |
27.03 | 21.48 | 15.01 | 8.58 | |
Capital Expenditures |
0.00 | 0.01 | 0.00 | — | |
Net Current Asset Value |
2.08 | (2.72) | (6.90) | (12.90) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.45 | 1.48 | 1.19 | 1.58 | |
Average Assets |
77.27 | 58.20 | 51.68 | 44.61 | |
Average Common Equity |
34.58 | 25.18 | 17.45 | 11.89 |
Columns are period end dates